1

CURRICULUMVITAE

Wahajuddin PhD, MNASc., MAMS

Senior Scientist, Division of Pharmacokinetics and Metabolism, Pre-Clinical North, Lab # 106, CSIR-Central Drug Research Institute (CDRI), Sector-10, Jankipuram Ext., Sitapur Road, Lucknow-226031 (U.P.) India Web- www.cdriindia.org/wahaju.htm

Residential Address: Staff Qtrs. E-29, CSIR-CDRI Campus, Sector 10, Janakipuram Ext., Sitapur Road Lucknow-226031 (U.P.) India Email- wahajuddin@gmail.com Cell No.0091-9956880015

Total Publications: 84 (2008 onwards) Book Chapters: 5 Patents: 6

Total Impact Factor: 313.66 Average Impact Factor: 3.73 h-index: 17 i10-index: 32 Researchgate Score: 37.10

Humboldt Research fellow, University of Cologne, Department of Pharmacology, Germany

Koln (Mar 2018-present)

Research and Teaching Experience: 11 years

Administrative Experience: 7 years as course coordinator (head of the department)

Extramural Research Projects Granted: 4 (value 96, 00, 000)

Post-doctoral Student guided: 1, PhD students guided: 5, Masters Students guided: 31

Technology Transfer: 2

Achievements, Awards & Prizes won:

• Humboldt Research Fellowship from Alexander von Humboldt Foundation, Germany

• Elected member, Indian National Young Academy of Sciences under the aegis of Indian National Science Academy New Delhi India

• Junior Investigator Award 2017 by Safety Pharmacological Society USA

• Young Scientist Award 2013-14 by State Government of Uttar Pradesh, India

• Young Scientist Award 2016 by International Union of Biochemistry and Molecular Biology at Vancouver, Canada

• TWAS/BVL.NXT2016 Fellow by Academy of Sciences in Developing World (TWAS) and the Foundation Pour l’Université de Lyon to present the research

2

finding in BioVision international conference at Lyon (France) during April 11thto 15th 2016 with full financial support (travel and local hospitality)

• DEF Young Scientist Award 2014from the Academy of Environmental Biology and Dalela Education Foundation

• ISMAS Young Mass Spectroscopist Award 2013 from Indian Society for Mass Spectrometry

• 8th Dr P.D. Sethi Annual Award 2012 for Best Paper in Pharmaceutical Analysis Sponsored by The Pharma Review

• Won ABAP Senior Scientist Gold Medal 2012 awarded by Association of Biotechnology & Pharmacy

• Won Nature Travel Fellowship Award of USD $1400 for presenting research findings at Miami Winter Symposium 2013 awarded by Miller School of Medicine, University of Miami, FL, USA

• Young Pharmaceutical Analyst Award 2012 from Indian Drug Manufacturer’s Association

• DBT- Cutting-edge Research Enhancement & Scientific Training (DBT-CREST) Award 2011-12 from Dept. of Biotech. Govt. of India to carry out advanced research for twelve months at Eshelman School of Pharmacy, University of North Carolina USA

• SERB-DST Fast Track Young Scientist Proposal Award 2011 from Dept. of Sc. & Tech. Govt. of India

• Selected as TWAS/BVA.NXT2012 Fellow by Academy of Sciences in Developing World (TWAS) and Bibliotheca Alexandria to present the research finding in BioVision international conference at Egypt during April 21st to 25th 2012 with full financial support (travel and local hospitality)

• Won Prof. A. K. Dey Award 2011 for Analytical and Environmental Chemistry by Indian Chemical Society

• Profile appeared in the international journal Bioanalysis as Young Investigator 2011

(PMID: 21510757).

• Best Poster Award in International Symposium on Green Chemistry & Chromatographic Sciences 2012 byIndian Society of Analytical Scientists

• Best poster award (won by my PhD student Ms. IshaTaneja) in 4th NIPER Raebareli-CDRI Symposium on Medicinal Chemistry and Pharmaceutical Sciences 2012

Technology Transfer:

• Successfully demonstrated and transferred the knowhow for pharmaceutical analysis work package for quality control of CSIR-CDRI product A-4744 as a part of technology transfer to Pharmanza Herbal Pvt Ltd, Dharmaj 388 435 Gujarat India. This product is marketed in India in Feb. 2016 with trade name Reunion®.

• Successfully demonstrated and transferred the knowhow for pharmaceutical analysis for quality control and pharmacokinetics work package of CSIR-CDRI product

3

Osteojuvanate (1020F147) as a part of technology transfer to Natural Remedies Pvt Ltd. Bengaluru, India

AcademicandProfessional Qualification:

Sr. No. Exam Institution /

College University

/Board Year of Passing

Class/ Div.

1 Humboldt Research fellow

Department of Pharmacology

University of Cologne,

Germany Koln

March 2018-

Present

2 Post Doctoral Research

UNC Eshelman School of Pharmacy

University of North Carolina at Chapel Hill,

NC, USA

2013-2014

3 PhD Pharmacy

CSIR- Central Drug Research

Institute Lucknow

Integral University Lucknow

2009-2012

4 M. S. (Pharm.)

National Institute of

Pharmaceutical Education and

Research (NIPER), Mohali

(Punjab)

National Institute of

Pharmaceutical Education and

Research (NIPER), Mohali

(Punjab)

2004-2006 First

5 General Course

on Intellectual Property

World Intellectual

Property Organization,

Geneva (Switzerland)

World Intellectual

Property Organization,

Geneva (Switzerland)

2006 First

6 B. Pharm. Dept. of Pharm.

Sciences

HNB Garh. Univ., Srinagar

(U.A.) 2003 First

7 Intermediate MDS Inter College,

Najibabad (UP) U.P. Board 1999 First

8 High School

Lala D. Ram SVMHSS,

Kiratpur (UP) --Do-- 1997 First

Dissertation projects Undertaken:

Worked for PhD (Pharm.) dissertation project entitled “Development of Validated

Methods and Pharmacokinetic Evaluation of Antimalarial Candidate Drug(s) and

4

Potential Combinations to Tackle the Problems of Emerging Drug Resistance”

during 2009-2012 at CSIR-CDRI Lucknow and degree awarded by Faculty of Pharmacy,

Integral University Lucknow.

Worked for M. S. (Pharm.) dissertation project entitled “Database Development and

QSAR Studies on Drugs and Drug-like Molecules Acting on Angiotensin II

Receptors” for one year duration during 2005-2006.

Worked duringM. S. (Pharm.) as summer trainee for ten week project entitled

"Data Mining for Anticancer Drug Discovery", at Supercomputer Education and

Research Centre, Indian Institute of Science (IISc), Bangalore, India.

Worked during B. Pharm. as summer trainee for ten week project entitled

"Antimicrobial Screening & Identification of Actinomycetes", at Regional Research

Laboratory (RRL-CSIR), Jammu (J&K), India

Employment and Experience: Sr

No

Period Place of Employment Designation Scale of pay Job profile

1. 25June2006

to

24Nov2006

Micro Laboratories

Limited, Bengaluru

Scientist, IP &

Tech Transfer

3 LPA IP Management & Tech

Transfer

1. 05Dec2006

to

04Dec 2009

CSIR Central Drug

Research Institute,

Lucknow

Junior

Scientist

(Lecturer)

Rs15600–39100

Grade pay 5400/-

Research & teaching in

Biopharmaceutics,

Pharmacokinetics and

Drug Metabolism

2. 05Dec2009

to

04Dec 2013

CSIR Central Drug

Research Institute,

Lucknow

Scientist

(Assistant

Professor)

Rs15600–39100

Grade pay 6600/-

Research & teaching in

Biopharmaceutics,

Pharmacokinetics and

Drug Metabolism

4. 13Jan2013

to

12Jan2014

UNC Eshelman

School of Pharmacy,

University of North

Carolina at Chapel

Hill, NC, USA

Visiting Scientist

(on deputation)

(Visiting

Assistant

Professor)

USD$3000 Research & teaching in

Biopharmaceutics,

Pharmacokinetics and

Drug Metabolism

3. 05Dec2013

till date

CSIR Central Drug

Research Institute,

Lucknow

Senior Scientist

(Associate

Professor)

Rs15600–39100

Grade pay 7600/-

Research & Teaching in

Biopharmaceutics,

Pharmacokinetics and

Drug Metabolism

5

4

March 2018-

Present

Department of Pharmacology, University of

Cologne, Germany Koln

Humboldt Research

fellow -- Pharmacology

Also given the responsibility to work as Course Coordinator (Head of Department

of Pharmaceutics)for M. S. (Pharm.) Pharmaceutics (since Sept. 14th 2010)

andvisiting faculty (since Nov. 19th 2008) at National Institute of Pharmaceutical

Education and Research (Institute of National Importance, Ministry of Chemicals

and Fertilizers), Raebareli, India. Since this institute (NIPER Raebareli) is very

young, my parent institute (CDRI) is acting as mentor institute for its development.

Courses taught for more than ten years:

Biopharmaceutics, Pharmacokinetics, Pharmaceutical Analysis, Drug Discovery &

Development, Pharmacological basis of drug action, Dosage Form Design,

Therapeutic Drug Monitoring, Advanced Drug Delivery Systems and Drug

Metabolism

Other Professional Accomplishment:

Registered Patent Agent with Indian Patent Office upon qualifying National level

examination.

Corporate Experience:

Worked as Founder Head, Dept. of Corporate I. P. with Micro Labs Ltd., Bangalore,

India during June 26th to Nov. 25th 2010. Job profile included looking after whole IP

portfolio of company for both Domestic and Overseas Markets.

Extramural Research Project Awarded:

“Novel small molecules as selective and positive allosteric modulators (PAM) of 5

HT2c receptors: Discovery and development of potential anti-obesity agents”

byDST, New Delhi for INR 71,00, 6000 as Co-Principal Investigator

"Investigation of uptake and efflux transporters role in first line prescription

medicines and CDRI candidate drug disposition, potential drug combination and

6

pharmacological effects by experimental therapeutic studies" by DST SERB for

INR 6, 00, 000 as Principal Investigator

“Role of Drug Transporters in the Efficacy of Metformin in Breast Cancer” by

Dept. of Biotechnology, Govt. of India for INR 25,00,000 as Principal

Investigator

“Pharmacokinetic, metabolic and biopharmaceutic assessment of lumefantrine

and it’s active and more potent metabolite” by Dept. of Sc. &Tech., Govt. of

India for INR 16,50,000 as Principal Investigator

“Preclinical development of orally active, rapid fracture healing agent.” by

Indian Council of Medical Research, Dept. of Health Research, Govt. of India for

INR 45,00,000 as Co-Principal Investigator

“Investigation of Pharmacokinetic Interaction Potential of Flavonoids on the

Absorption and Metabolic Fate of Antimalarial Compounds” by CSIR for INR

4.72 lacs per year as Principal Investigator

Human Resource Development (students guided)/Training Imparted:

Post Doctoral Fellow:

Dr. Sadaf Jahan project entitled "Investigation of uptake and efflux transporters role in

first line prescription medicines and CDRI candidate drug disposition,potential drug

combination and pharmacological effects by experimental therapeutic studies"

Ph.D.:

1. Ms. Isha Taneja thesis entitled “Preclinical Pharmacokinetic Characterization of

Medicarpin and Prediction of its Human Pharmacokinetic Using Species Invariant

Time Approach Based on Allometry Concept” (Awarded) (Currently working as

scientist at BMS)

2. Mr. KSR Raju thesisentitled “Investigation of Preclinical Pharmacokinetics of

Isoformononetin, A Potential Anti-Osteoporotic Compound and Isoflavones-Drug

Interactions” (Awarded) (Currently working at university of Cincinnati, US)

3. Mr. Mamunur Rashid dissertation continuing

4. Mr. Sandeep K Singh dissertation continuing

5. Arun Kumar dissertation continuing

7

Project Fellows:

1. Mr. Mohd Yaseen Malik

2. Ms. Swati Chaturvedi

Masters:

1. Ms. Chandrika Rana, M. Pharm. (Pharmaceutics) dissertation entitled

“Pharmacokinetic Evaluation of Antimalarial(s) in Pre-Clinical Species Using

Validated Method”

2. Ms. AnshulVarshney, M. Sc. (Biotechnology) summer training entitled

“Evaluation of S008-399 and S007-1500 stability in simulated Gastro-intestinal

fluids using HPLC”

3. Mr. DivyeshTewari, M. Pharm. (Pharmaceutics) dissertation entitled

“Development and Validation of HPLC method for quantification of Nobiletin in

Rat Plasma and Brain: Application to Pharmacokinetic Study”

4. Mr.Kushal Kumar Patel, M. S. (Pharm.) Pharmaceutics dissertation entitled

“PAMPA and SPIP Rat Permeability Model Standardization using FDA

Approved Markers: Application to Permeability Determination of Test

Compounds”

5. Ms. Amreen Zia, M. Tech. Biotechnology dissertation entitled “Development

and Validation of RP-HPLC Method for Simultaneous Determination of

Withanolides (Withaferin A, Withanolide A and Withanone)”

6. Mr.KSR Raju, M. S. (Pharm.) Pharmaceutics dissertationentitled“Exploration of

Role of P-Glycoprotein in Absorption of Antimalarial Drug (Lumefantrine) Using

Standardized Permeability Models”.

7. Mr.AsadNafis, M. S. (Pharm.) Pharmaceutics dissertation“In Vitro-In vivo

Pharmacokinetic Evaluation of Antimalarial Drug (Lumefantrine)”.

8. Ms. Garima Pandey, M. Tech. PharmaceuticalBiotechnologydissertation

entitled “Permeability Determination of Withanolides (withanolide A and

withanone) using Single Pass Intestinal Perfusion Technique in Rats”.

9. Ms. Saba Amir M. Pharm. Pharmaceutics dissertation entitled “Permeability

Assessment of Antimalarial using in situ Permeability Model”.

10. Ms. Shiny PanigrahiM. Pharm. dissertation entitled “Effect of Flavonoids on

the Pharmacokinetics of Statins.”

8

11. Ms. IshaTanejaM. S. (Pharm.) Pharmaceutics dissertation entitled “Preclinical

in vitro Pharmacokinetics of Desbutyl-lumefantrine.”

12. Mr. SumitAroraM. S. (Pharm.) Pharmaceutics dissertation entitled “Effect of

Potential Anti-osteoporotic Agents on Major Cytochrome P450 Isoforms.”

13. Ms. Nida, M. Pharm. Pharmaceutics dissertation entitled “Excretion Studies of

Lumefantrine and its Metabolite Desbutyl-lumefantrine”

14. Ms. Sumaira, M. Pharm. Pharmaceutics dissertation entitled “Investigation of

Inhibitory Effect of CDRI Candidate Anti-osteoporotic Agents on CYP Isoforms”

15. Ms. UmmeBushra, M.Pharm. Pharmaceutics dissertation entitled

“Determination of CYP Inhibitory Potential of S008-398 in Rat Liver

Microsomes”

16. Mr. GundetiManoj, M.S. (Pharm.) Pharmaceutics dissertation entitled

“Investigation of Pharmacokinetic Interaction Potential of Dexamethasone and

Raloxifene”

17. Ms. ErukalaMadhuri, M.S. (Pharm.) Pharmaceutics dissertation entitled

“Investigation of Pharmacokinetic Interaction Potential of Morin on

Lumefantrine”

18. Mr. Muralikrishna, M.S. (Pharm.) Pharmaceutics dissertation entitled

“Bioanalytical method development and validation of CDRI Candidate anti-

osteoporotic compound and its application to preclinical pharmacokinetic study

and drug-drug interactions”

19. Mr. Gampa Srinivas, M.S. (Pharm.) Pharmaceutics dissertation entitled

“Preclinical Pharmacokinetic Profiling of Potential Anti-osteoporotic Agent,

Medicarpin”

20. Mr. Balaveer Ram,M.S. (Pharm.) Pharmaceutics dissertation entitled

“Pharmacokinetic drug interaction potential of Dihydroartemisinin –

Desbutyllumefantrine combination.”

21. Ms. KattupalliPreethi,M.S. (Pharm.) Pharmaceutics dissertation entitled

“Investigation of Pharmacokinetic Herb-Drug Interactions”

22. Mr.BhalalaKripalBabubhai M.S.(Pharm.) Pharmaceutics

dissertationentitled“Development and Evaluation of Lumefantrine Loaded Solid

Lipid Nanoparticles to Inhibit P-glycoprotein Efflux and Enhance Oral

Bioavailability”

9

23. Mr. TomarDevendra Singh M.S. (Pharm.) Pharmaceuticsdissertationentitled

“Formulation and Evaluation of Artemether Loaded Solid Lipid Nanoparticles”

24. Shaheen Ansari, M.Pharm. Pharmaceutics dissertation entitled “In vitro

Biopharmaceutical Assessment of CSIR-CDRI New Chemical Entities”

25. Dheeraj Kumar Jha, M.S. (Pharm.) Pharmaceutics dissertation submitted

26. Rage Vinod Kumar, M.S. (Pharm.) Pharmaceutics dissertation submitted

27. Khushboo K, M.Pharm. Pharmaceutics dissertation submitted

28. Asish Kumar, M.S. (Pharm.) Pharmaceutics dissertation continuing

29. Mahaveer, M.S. (Pharm.) Pharmaceutics dissertation continuing

30. Kanika, M.Pharma Pharmaceutics dissertation continuing

Patents:

Sr. No.

Title Inventors Date of Filing

App No

1. Dalbergiasisso derived extract and compounds employed in prevention or treatment of osteo-health related disorders.

Rakesh Maurya, P Dixit, R Trivedi, VKhedgikar, JGautam, A Kumar, D Singh, SP Singh, Wahajuddin, GKJain, N Chattopadhyay

25/04/2012 PCT/IN2012/000301

2. A novel chemically modified bioactive fraction from Curcuma longa [NCCL] for management of CVS and CNS disorders

Anil Kumar Dwivedi, A Naqvi, RMalasoni, M Rana, R R Pandey, A Srivastava, A Manhas,ITaneja, Wahajuddin, P K Srivstava, KJagavelu, M K Barthwal& Ram Pratap

11/07/2014 1940DEL2014

3. Dalbergiasisso derived extract and compounds employed in prevention or treatment of osteo-health related disorders designated as osteoNATURAL care

Rakesh Maurya, Preety Dixit, Ritu Trivedi, VikramKhedgikar, JyotiGautam, Avinash Kumar, Divya Singh, ShelendraPratap Singh, Wahajuddin, Girish Kumar Jain &Naibedya Chattopadhyay

22/10/2013 12729239.9

4. Dalbergiasisso derived RakeshMaurya, Preety 23/10/2013 14/113561

10

extract and compounds employed in prevention or treatment of osteo-health related disorders designated as osteoNATURALcare

Dixit, Ritu Trivedi, VikramKhedgikar, JyotiGautam, Avinash Kumar, Divya Singh, ShelendraPratap Singh, Wahajuddin, Girish Kumar Jain &Naibedya Chattopadhyay

5. Dalbergiasisso derived extract and compounds employed in prevention or treatment of osteo-health related disorders.

Rakesh Maurya, Preety Dixit, Ritu Trivedi, VikramKhedgikar, JyotiGautam, Avinash Kumar, Divya Singh, ShelendraPratap Singh, Wahajuddin, Girish Kumar Jain, Naibedya Chattopadhyay

25/04/2012 1206DEL2011

6. 2-Benzyltetralin compounds as anticancer agents and the process of preparing the same.

Arvind Singh Negi, Y Gautam, S Luqman, K Fatima, D Chanda, A Singh, Wahajuddin, I Taneja.

0012NF2017

11

Publications at a glance (2008 onwards):

S.No Journal Year No. Of Publications

Impact Factor

1 Curr. Med. Chem. 2017 1 3.45

2 Drug Deliv Transl Res. 2017 1 1.88

3 J Chromatogr Sci 2017 1 1.32

4 Drug Metab. Rev. 2016 2 4.52

5 Bioorg. Med. Chem. Lett. 2016 1 2.4

6 Int. J. Pharm. 2016 1 3.65

7 Nature Biotechnology 2016 1 43.5

8 Toxicol Appl Pharmacol. 2016,16 2 3.71

9 Int J Infect Dis 2016 1 1.85

10 J. Nat. Prod. 2016 1 3.79

11 Curr Pharm Des. 2016 1 5.57

12 Eur. J. Med. Chem. 2016,16 1 3.44

13 Sci. Rep. 2015,15, 16, 16 4 5.5

14 Toxicol. Lett. 2015 1 3.3

15 J. Anal. Toxicol. 2016 1 2.85

16 ActaNeurobiol. Exp. 2015 1 1.52

17 Drug Testing Anal. 2015,16 2 2.81

18 Crit. Rev. Food Sci. Nutr. 2015 1 5.54

19 Phytochem Rev. 2015 1 2.89

20 Colloid Surface B 2015 1 4.29

21 Antimicrob. Agents Chemotherap. 2014 2 4.57

22 Free Radic. Bio. Med. 2014 1 5.27

23 Int. J. Pharmaceut. 2014 1 3.46

24 Indian J. Pharmaceut. Sci. 2014 1 0.3

25 RSC Adv. 2014,14,14,15,15 5 3.71

26 Cancer Res. 2014 1 9.28

27 Bioanalysis 2011,13,14,15 4 3.25

28 Biomed. Chrom. 2013 1 1.95

29 Phytomedicine 2013 1 2.97

30 TrAC-Trend. Anal. Chem. 2013 1 6.35

31 Curr. Drug Metab. 2013 1 4.41

32 J. Med. Chem. 2013, 16 1 5.61

33 ACS Med. Chem. Lett. 2013 1 3.31

34 AAPS J. 2010,10,13,13 4 4.38

35 Menopause 2010,12 2 3.16

36 Int. J. Nanomed. 2012 1 3.46

37 J. Pharmaceut. Biomed. Anal. 2012, 16, 16,18 4 2.95

38 Biopharm. Drug Dispos. 2012 1 2.09

12

39 Phytotherap. Res. 2012 1 2.07

40 Malaria J. 2011,15 2 3.4

41 Mut. Res.-Gen. Tox. Env. Mutagenesis

2011 1 2.22

42 Fitoterapia 2011 1 2.23

43 J. Chromatgr. B 2008,09,10,11,15 5 2.48

44 Med. Chem. Res. 2010,11 2 1.61

45 ArzneimittelForsch/Drug Res. 2011 1 0.59

46 Food and Chem. Toxicol. 2011,18 2 3.01

47 Curr. Pharm. Anal. 2011 1 1.33

48 J. Pharm. Pharmacol. 2011 1 2.03

49 J. Nutr. Biochem. 2011 1 4.55

50 J. Sep. Sci. 2010 1 2.59

51 Crystal Growth & Design 2018 1 4

52 Neurotox Res 2018 1 3.5

53 Biochim Biophys Acta. 2018 1 3.6

Cumulative impact factor 313.66

Year-wise list of publications

2018

Corresponding author

1. Rashid M, Singh SK, Malik MY, Jahan S, Chaturvedi S, Taneja I, Raju KS, Zaiba Naseem, Gayen JR, Wahajuddin M§. Development and validation of UPLC-MS/MS assay for quantification of Cladrin: Absolute bioavailability and dose proportionality study in rats. Journal of pharmaceutical and biomedical analysis, 152, 289-297 (§Corresponding author) (Impact Factor- 2.9)

Co-author

2. Ahmad U, Akhtar J, Singh SP, Ahmad BFJ, Siddiqui S, Wahajuddin M. Silymarin nanoemulsion against human hepatocellular carcinoma: development and optimization. Artificial cells, nanomedicine, and biotechnology. 46, 231-41. (Impact Factor- 2.2)

3. Mehta BK, Shiv, Singh S, Chaturvedi, Wahajuddin M, Thakur TS, (2018). Rational Coformer Selection and the Development of New Crystalline Multicomponent Forms of Resveratrol with Enhanced Water Solubility. Crystal Growth & Design, 18, 1581-1592. (Impact Factor- 4.0)

4. Taneja I, Karsauliya K, Rashid M, Sonkar AK, Raju KSR, Singh SK, Das M, Wahajuddin M, Singh SP, (2018), Species differences between rat and human in vitro metabolite profile, in vivo predicted clearance, CYP450 inhibition and CYP450

13

isoforms that metabolize benzanthrone: Implications in risk assessment, Food and Chemical Toxicology, 111, 94-101, (Impact Factor- 3.8)

5. Verma DK, Gupta S, Biswas J, Joshi N, Sivarama Raju K, Wahajuddin M, Singh S. (2018), Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation. Neurotox Res. doi: 10.1007/s12640-018-9878-2. (Impact Factor- 3.5)

2017

Corresponding author

6. Verma DK, Gupta S, Biswas J, Joshi N, Singh A, Gupta P, Tiwari S, Raju K, Chaturvedi S, Wahajuddin M, Singh S. (2018) New therapeutic activity of metabolic enhancer piracetam in treatment of neurodegen-erativedisease: Participation of caspase independent death factors, oxidative stress, inflammatory responses and apoptosis. Biochim Biophys Acta. 1864, 2078-2096. (Impact Factor- 3.6)

7. Anuj Garg, Kripal Bhalala, Devendra Singh Tomar, Wahajuddin M§ (2016). In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles. International Journal of Pharmaceutics, 516, (1–2):120–130 PMID:27989820 (§Corresponding author) (Impact Factor- 3.65)

8. Raju KSR, Gundeti M, Malik MY, Kadian N, Rashid M, Taneja I, Singh SP,

Wahajuddin M§ (2017)Bioanalysis of antitubercular drugs using liquid chromatography. J Pharm Biomed Anal. 134:295-309.PMID:27951471 (§Corresponding author) (Impact Factor- 2.9)

9. Mohd Yaseen Malik, Isha Taneja, Kanumuri Siva Rama Raju, JiaurRahamanGayen, Sheelendra Pratap Singh, Muhammad Wahajuddin§. RP-HPLC Separation of Isomeric Withanolides: Method Development, Validation andApplication to In situ Rat Permeability Determination. Journal of Chromatographic Science. (Manuscript accepted)(§Corresponding author) (Impact Factor- 1.32)

Co-author

10. Sadaf Jahan, Dipak Kumar, Swati Chaturvedi, Mamunur Rashid, Muhammad Wahajuddin, Yasir Akhtar Khan, Sameer N. Goyal, C. R. Patil, Rajesh Mohanraj, Sandeep Subramanya and ShreeshOjha. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases. Current Medicinal Chemistry, (Manuscript Accepted) DOI: 10.2174/0929867324666170227121619. (Impact Factor-3.455)

14

11. Anand D, Yadav PK, Patel OP, Parmar N, Maurya RK, Vishwakarma P, Raju KS,

Taneja I, Wahajuddin M,Kar S, Yadav PP. (2017)Antileishmanial Activity of Pyrazolopyridine Derivatives and their Potential as Adjunct Therapy with Miltefosine.J Med Chem. 2017, 60 (3), 1041–1059. PMID:28059524 (Impact Factor-5.589)

12. Singh N, Singh H, Jagavelu K, Wahajuddin M, Hanif K (2017) Fatty acid synthase modulates proliferation, metabolic functions and angiogenesis in hypoxic pulmonary artery endothelial cells. European Journal of Pharmacology, In press.(Impact Factor- 2.9)

13. Singh SK, Makadia V, Sharma S, Rashid M, Shahi S, Mishra PR, Wahajuddin M, Gayen JR. Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration. Drug Delivery and Translational Research. 2017 Feb 13:1-3.(Impact Factor- 1.88)

14. Usama Ahmad, Juber Akhtar, Satya Prakash Singh, Badruddeen, Farhan Jalees Ahmad, Sahabjada Siddiqui &Wahajuddin (2017) Silymarinnanoemulsion against human hepatocellular carcinoma: development and optimization. Artificial Cells, Nanomedicine, and Biotechnology. Accepted. DOI: 10.1080/21691401.2017.1324465(Impact Factor- 2.0)

2016

Corresponding author

15. Kadian N, Raju KS, Rashid M, Malik Y, Taneja I and Wahajuddin M§(2016) Comparative Assessment of Bioanalytical Method Validation Guidelines for Pharmaceutical Industry. Journal of Pharmaceutical and Biomedical Analysis. 126:83-97. PMID:27179186 (§Corresponding author) (Impact Factor- 2.9)

16. Raju KS, Taneja I, Rashid M, Sonkar AK, Wahajuddin M§, Singh SP§(2016) DBS-platform for biomonitoring and toxicokinetics of toxicants: proof of concept using LC-MS/MS analysis of fipronil and its metabolites in blood. Scientific Reports. 6:22447.PMID: 26960908(§Corresponding author)(Impact Factor-5.578)

17. Singh SP, Dwivedi N, Raju KS, Taneja I, Wahajuddin M§(2016). Method Coupled with Protein Precipitation for the Simultaneous Determination of Seven Pyrethroids in 100 µL of Rat Plasma by Using Ammonium Adduct as Precursor Ion. Journal of Analytical Toxicology. 40(3):213-21. PMID: 26801239 (§Corresponding author)(Impact Factor- 2.85)

18. Wahajuddin M§, Taneja I, Raju K, Rashid M (2016). Pharmacokinetic Endeavors for Antimalarial Therapeutics. International Journal of Infectious Diseases. 45: 130-131.(§Corresponding author)(Impact Factor-1.859)

19. Taneja, Isha; Raju, Kanumuri Siva Rama; Arora, Sumit; Jain, Sanyog; Singh, SheelendraPratap; Wahajuddin, M§. (2016). Effect of polymorphism on the preclinical pharmacoknetics of desbutyl -lumefantrine, a potential anti -malarial

15

agent. Drug Metabolism Reviews48; 32 .(§Corresponding author)(Impact factor-4.526).

20. Raju, Kanumuri Siva Rama; Taneja, Isha; Singh, SheelendraPratap; Wahajuddin, M§.(2016). Preclinical pharmacokinetics and species differences in the CYP -mediated metabolism of isoformononetin, a potential anti -osteoporotic isoflavonoid. Drug Metabolism Reviews 48; 49 .(§Corresponding author)(Impact factor -4.526).

21. WahajuddinM§, Singh SP, Taneja I, Raju KSR, Gayen JR, Siddiqui HH, Singh SK. (2016). Development and validation of a LC-MS/MS method for simultaneous determination of piperaquine and 97-63, the active metabolite of CDRI 97-78, in rat plasma and its application in interaction study. Drug Testing and Analysis. (2), 221–227.PMID: 25975936.(§Corresponding author)(Impact factor -2.85).

Co-author

22. Shukla AK, Upadhyay SK, Mishra M, Saurabh S, Singh R, Singh H, Thakur N, Rai P, Pandey P Nair K N, Bhadauria S, Wahajuddin M, Singh S, Sharma S, Ranade SA, Tuli R, Singh PK. (2016) Expression of an insecticidal fern protein in cotton protects against whitefly. PMID: 27598229. Nature Biotechnology. 34,1046–1051(Impact Factor- 43.5)

23. Dola VR, Soni A, Agarwal P, Ahmad H, Raju KS, Rashid M, WahajuddinM, Srivastava K, Haq W, Dwivedi AK, Puri SK and Katti SB. (2016).Synthesis and evaluation of chirally defined side chain variants of 7-chloro- 4-aminoquinoline to overcome drug resistance in malaria chemotherapy.PMID:27956423. Antimicrobial Agents and Chemotherapy. AAC-01152.(Impact Factor-4.415)

24. Pal S, Khan K, China SP, Mittal M, Porwal K, Shrivastava R, Taneja I, Hossain Z, Mandalapu D, Gayen JR, Wahajuddin M, Sharma VL, Trivedi AK, Sanyal S, Bhadauria S, Godbole MM, Gupta SK, Chattopadhyay N. (2016) Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats.ToxicolApplPharmacol.295:12-25.PMID: 26851681(Impact Factor-3.71)

25. Mittal M, Pal S, China SP, Porwal K, Dev K, Shrivastava R, Raju KS, Rashid M, Trivedi AK, Sanyal S, Wahajuddin M, Bhaduria S, Maurya R, Chattopadhyay N. (2016) Pharmacological activation of aldehyde dehydrogenase 2 promotes osteoblast differentiation via bone morphogenetic protein-2 and induces bone anabolic effect.ToxicolApplPharmacol.316:63-73.PMID: 28017615 (Impact Factor-3.71)

26. Patel O, Mishra A, Maurya R, Saini D, Pandey J, Taneja I, Raju KS, KanojiyaS, ShuklaS, SrivastavaM,WahajuddinM, Tamrakar A, Srivastava A, Yadav P. (2016)Naturally Occurring Carbazole Alkaloids from Murrayakoenigii as Potential Antidiabetic Agents. Journal of Natural Products.79(5):1276-84. PMID: 27136692 (Impact Factor-3.798)

27. Gupta A, Ahmad I, Kureel J, John AA, Sultan E, Chanda D, Agarwal NK, Alauddin, Wahajuddin, PrabhakerS, VermaA, SinghD (2016) Differentiation of skeletal osteogenic progenitor cells to osteoblasts with 3,4-diarylbenzopyran based amide derivatives: Novel osteogenic agents. European Journal of Medicinal Chemistry.121:82-99.PMID: 27236065 (Impact factor: 3.44)

28. Valicherla G, Dave K, Syed AA, Riyazuddin M, Gupta A, Singh A, Wahajuddin M, Mitra K, Datta D and Gayen JR (2016) Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity. Scientific Reports. 6:26895. PMID: 27241877 (Impact factor: 5.578)

16

29. Ahmad J, Akhter S, Khan MA, Wahajuddin M, Greig NH, Kamal MA, Midoux P, Pichon C. (2016). Engineered nanoparticles against MDR in cancer: The state of the art and its prospective. Curr Pharm Des.22(28):4360-73.PMID: 27319945 (Impact factor: 5.578)

30. Mandalapu D, Saini KS, Gupta S, Sharma V, Malik MY, Chaturvedi S, Bala V, Hamidullah, Thakur S, Maikhuri JP, Wahajuddin M,Konwar R, Gupta G, Sharma VL(2016).Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines. Bioorganic & Medicinal Chemistry Letters, (17), 4223–4232.(Impact factor-2.4).

2015

Corresponding author 31. Taneja I, Raju KSR,Singh SP, Wahajuddin M§ (2015) Assessment of

pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99-411, with long acting prescription antimalarials, lumefantrine and piperaquine. Scientific Reports. 5:17264. PMID: 26602250 (§Corresponding author)(Impact Factor-5.578)

32. Taneja I, Raju KSR and WahajuddinM§(2015) Dietary isoflavones as modulators of drug metabolizing enzymes and transporters: Effect on prescription medicines. Critical Reviews in Food Science and Nutrition. PMID: 26561312 (§Corresponding author) (Impact Factor -5.58)

33. Raju KSR,Taneja I, Valicherla GR, Challagundla MK, GayenJR,Singh SP, Wahajuddin M§ (2015)No effect on pharmacokinetics of tamoxifen and 4-hydroxytamoxifen by multiple doses of red clover capsule in rats. Scientific Reports. 5:16126.PMID: 26530625 (§Corresponding author)(Impact Factor-5.578)

34. Taneja I, Raju KSR, Mittal M, Dev K, Khan MF, Maurya R and Wahajuddin M§ (2015) Oral bioavailability, intravenous pharmacokinetic, plasma protein binding and metabolic stability studies of ALDH2 activator, alda-1, using validated LC-ESI-MS/MS method in rat plasma. RSC Advances.5: 54395-54402(§Corresponding author)(Impact Factor-3.7)

35. Arora S, Taneja I, Challagundla M, Raju KSR, Singh SP, Wahajuddin M§(2015)In vivo prediction of CYP-mediated metabolic interaction potential of formononetin and biochanin A using in vitro human and rat CYP450 inhibition data. Toxicology Letters. 239(1):1-8.PMID: 26278343 (§Corresponding author)(Impact Factor-3.3)

36. Taneja I, Raju KSR, Challagundla M, Raghuvanshi A, Goel A, WahajuddinM§ (2015) LC-ESI-MS/MS method for bioanalytical determination of osteogenic phytoalexin, medicarpin, and its application to preliminary pharmacokinetic studies in rats. J Chromatography B. 1001:9-16.PMID:26241182(§Corresponding author)(Impact Factor-2.7)

37. WahajuddinM§, Singh SP, Taneja I, Raju KSR, Gayen JR, Siddiqui HH, Singh SK (2015) Simultaneous quantification of proposed anti-malarial combination comprising of lumefantrine and CDRI 97-78 in rat plasma using the HPLC–ESI-MS/MS method: Application to drug interaction study. Malaria J. 14(1):172. PMID: 25895956 (§Corresponding author) (Impact Factor – 3.49)

17

38. Raju KSR, Taneja I, Singh SP, Tripathi A, Mishra DP, Hussain KM, Gayen JR, Singh SK and Wahajuddin M§ (2015). Simultaneous determination of Centchroman and tamoxifen along with their metabolites in rat plasma using LC-MS/MS. Bioanalysis.7(8):967-979. PMID: 25966009 (§Corresponding author) (Impact Factor-3.25)

39. Raju KS, Kadian N, Taneja I and Wahajuddin M§(2015) Phytochemical analysis of isoflavonoids using liquid chromatography coupled with tandem mass spectrometry. Phytochemistry Reviews :1-30 (2015) §Corresponding author) (Impact Factor-2.89)

Co-author 40. Dwivedi P, Khatik R, Chaturvedi P, Khandelwal K, Taneja I, Raju KS, Dwivedi H,

Singh S, Gupta PK, Shukla P, Tripathi P, Singh S, Tripathi R, Wahajuddin, Paliwal SK, Dwivedi AK and Mishra PR (2015). Arteethernanoemulsion for enhanced efficacy against Plasmodium yoeliinigeriensis malaria: An approach by enhanced bioavailability. Colloid Surface B.126:467-75 PMID 25616971 (Impact Factor -4.29)

41. Singh S, Chauhan P, Ravi M, Taneja I, Wahajuddin, Yadav PP (2015) A mild CuBr-NMO oxidative system for the coupling of anilines leading to aromatic azo compounds. RSC Advances.5:61876-61880(Impact Factor-3.7)

42. Verma DK, Joshi N, Raju KS, Wahajuddin M, Singh RK, Singh S (2015) Metabolic enhancer piracetam attenuates rotenone induced oxidative stress: a study in different rat brain regions. ActaNeurobiolExp 75: 399–411 (Impact Factor-1.52)

2014 Corresponding author

43. Wahajuddin§,Kanumuri Siva Rama Raju, SheelendraPratap Singh and IshaTaneja (2014) Investigation of Functional Role of P-glycoprotein in Limiting the Oral Bioavailability of Lumefantrine. Antimicrobial Agents and Chemotherapy. 58(1):489-494. PMID: 24189249 (§Corresponding author) (Impact Factor-4.5)

Co-author 44. CaiH, WahajuddinM, EverettR, ThakkerDR. (2014) Do cation-selective transporters

help or hurt the antitumor efficacy of metformin in breast cancer. Cancer Res. 74(19): 4639-4639. 2014. (Impact Factor-9.2)

45. Dwivedi P, Khatik R, Khandelwal K, Srivastava R, Taneja I, Raju KS,Dwivedi H, Shukla P, Gupta P, Singh S, Tripathi R, Paliwal SK, Wahajuddin, Dwivedi AK and Mishra PR. (2014) Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of arteether: pharmacokinetics, toxicity and antimalarial activity in mice. RSC Advances.4:64905-64918 (Impact Factor-3.7)

46. ChauhanP, RaviM, SinghS,RajuKS, BajpaiV, KumarB, Wahajuddin and Yadav PP. (2014) Palladium and copper-catalyzed ligand-free coupling of phenylhydrazines in water. RSC Advances. 4(82): 43336-43340. (Impact Factor-3.7)

47. Sonam Gupta; Dinesh K Verma; Joyshree Biswas; Sivaram K Raju; Neeraj Joshi; Wahajudin; SarikaSingh(2014)The metabolic enhancer piracetam attenuates the mitochondrion-specific endonuclease-G translocation and oxidative DNA fragmentation. Free Radical Biology & Medicine. 73C:278-290.(Impact Factor-5.3)

48. Dwivedi P, Khatik R, Khandelwal K, Taneja I, Raju KS, Wahajuddin, Paliwal SK, Dwivedi AK, Mishra PR. (2014) Pharmacokinetics study of arteether loaded solid

18

lipid nanoparticles: An improved oral bioavailability in rats.International Journal of Pharmaceutics. 466(1-2):321-327.PMID: 24657144

49. Tripathi A, Singh SP, Raju KSR, Wahajuddin and Gayen JR (2014) Effect of Red Clover on CYP Expression: An Investigation of Herb-Drug Interaction at Molecular Level. Indian Journal of Pharmaceutical Sciences. 76(3): 261-266.

2013

Corresponding author 50. IshaTaneja, MadhuriErukala, Kanumuri Siva Rama Raju, SheelendraPratap Singh and

Wahajuddin§ (2013). Dried Blood Spots in Bioanalysis of Antimalarials: Relevance and Challenges in Quantitative Assessment of Antimalarial Drugs. Bioanalysis. 5(17):2171-86. PMID: 23962252. (§Corresponding author) (Impact Factor-3.2)

51. Kanumuri Siva Rama Raju, IshaTaneja, SheelendraPratap Singh and Wahajuddin§ (2013) Utility of non-invasive biomatrices in pharmacokinetic studies. Biomedical Chromatography. 27(10):1354-66. PMID: 23939915.(§Corresponding author) (Impact Factor-1.9)

52. Wahajuddin§, Kanumuri Siva Rama Raju, IshaTaneja (2013) Bioanalysis of antimalarials using liquid chromatography. TrAC Trends in Analytical Chemistry. 42: 186-204. (§Corresponding author) (Impact Factor-6.273)

53. Wahajuddin§, IshaTaneja, Sumit Arora, Kanumuri Siva Rama Raju, Nida Siddiqui (2013) Disposition of Pharmacologically Active Dietary Isoflavones in Biological Systems. Current Drug Metabolism. 14(4):369-80. PMID: 23330931 (§Corresponding author) (Impact Factor-5.113)

54. Wahajuddin, Kanumuri Raju, IshaTaneja, Amit Tripathi, Durga Mishra (2013) “Drug-Drug Interaction Potential Assessment of Tamoxifen and Centchroman”AAPS Journal. W4275

Co-author

55. Srivastava K, Tyagi AM, Khan K, Dixit M, Lahiri S, Kumar A, Changkija B, Khan MP, Nagar GK, Yadav DK, Maurya R, Singh SP, Jain GK, Wahajuddin, Trivedi R, Chattopadhyay N, Singh D. (2013) Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis. Phytomedicine. 20(6):470-480. PMID: 23395215 (Impact Factor-3.268)

56. NarenderTadigoppula, VenkateswarluKorthikunta, Shweta Gupta, PapireddyKancharla, TanvirKhaliq, AwakashSoni, Rajeev Kumar Srivastava, Kumkum Srivastava, Sunil Kumar Puri, Kanumuri Siva Rama Raju, Wahajuddin, Puran Singh Sijwali, Vikash Kumar, and Imran Siddiqi Mohammad (2013) Synthesis and Insight into the Structure–Activity Relationships of Chalcones as Antimalarial Agents. J. Med. Chem., 56(1):31-45. PMID: 23270565(Impact Factor-5.248)

57. RanjaniMaurya, AwakashSoni, DevireddyAnand, Makthala Ravi, Kanumuri S. R. Raju, IshaTaneja, Niraj K. Naikade, S. K. Puri, Wahajuddin, Sanjeev Kanojiya, and Prem P. Yadav (2013) Synthesis and Antimalarial Activity of 3,3-Spiroanellated 5,6-Disubstituted 1,2,4-Trioxanes. ACS Med. Chem. Lett., 4(2): 165–169.(Impact Factor-3.355)

58. HaoCai, Wahajuddin, Ravindra Alluri, Ruth Everett, DhirenThakker(2013) “Cation-Selective Transporters are Critical Determinants of the Anti-proliferative Effects of Metformin in Breast Cancer Cells” AAPS Journal.W4368

19

2012

Corresponding author 59. Wahajuddin§and Sumit Arora (2012). Superparamagnetic iron oxide nanoparticles:

Magnetic nanoplatforms as drug carriers. International Journal of Nanomedicine,(7): 3445-3471. PMID:22848170 (§Corresponding author) (Impact Factor-4.976)

60. Wahajuddin§, SheelendraPratap Singh, KSR Raju, Nafis A and Girish Kumar Jain (2012) Simultaneous determination of nine model compounds in permeability samples using RP-HPLC: Application to prove the cassette administration principle in single pass intestinal perfusion study in rats. Journal of Pharmaceutical and Biomedical Analysis.67-68:71-76. PMID: 22613582 (§Corresponding author) (Impact Factor- 2.733)

61. Wahajuddin§,SheelendraPratap Singh and Girish Kumar Jain (2012). Gender differences in pharmacokinetics of lumefantrine and its metabolite desbutyl-lumefantrine in rats. Biopharm Drug Disposition. 33(4):229-34. PMID: 22447530 (§Corresponding author) (Impact Factor-1.394)

62. SheelendraPratap Singh*, Wahajuddin*§, KSR Raju, Mushir M. Ali, KanchanKohli, Girish Kumar Jain (2012) Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats. Phytotherapy Research.26(2):303-7. PMID: 22131128 (*Authors contributed equally; §Corresponding author)(Impact Factor-1.81)

Co-author

63. VikramKhedgikar, JyotiGautam, Priyanka Kushwaha ,Avinash Kumar, Geet K. Nagar, Preety Dixit, Raju Chillara, SwathiVoruganti, Sheelendra P. Singh, Wahaj Uddin, Girish K. Jain, Divya Singh, Rakesh Maurya, Naibedya Chattopadhyay, Ritu Trivedi (2012) A standardized phytopreparation from an Indian medicinal plant (Dalbergiasissoo) has antiresorptive and bone-forming effects on a postmenopausal osteoporosis model of rat. Menopause 19(12): 1. PMID: 22850441 (Impact Factor-3.318)

64. Chakraborty J, Hossain MZ, Tripathi A, Ghosh W, Samanta TB, Wahajuddin and Gayen JR (2012) Taxonomical characterization of a penicillin amidase producing novel strain of Achromobacterxylosoxidans: Proposal of A. xylosoxidans subsp. indiges subsp. nov.Developmental Microbiology and Molecular Biology. 3(1): 55-65.

2011

Corresponding author 65. Wahajuddin§,SheelendraPratap Singh, Sunil Kumar Puri and Girish Kumar Jain

(2011) Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats. Malaria Journal,10(1):293. PMID: 21985153 (§Corresponding author) (Impact Factor-3.49)

66. SheelendraPratap Singh*, Wahajuddin*§, Divyesh Tewari1, Kushalkumar Patel, Girish Kumar Jain (2011) Permeability determination and pharmacokinetic study of

20

nobiletin in rat plasma and brain by validated high-performance liquid chromatography method. Fitoterapia 82 (8): 1206-14. PMID: 21888953 (*Authors contributed equally; §Corresponding author) (Impact Factor-1.81)

67. SheelendraPratap Singh*, Wahajuddin*§,Mushir M. Ali, KanchanKohli, Girish Kumar Jain (2011) Liquid chromatography–mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: Application to interaction study with biochanin A (an isoflavone). Journal of Chromatgraphy B.879(27): 2845-2851.PMID: 21890435 (*Authors contributed equally; §Corresponding author) (Impact Factor-2.97)

68. Singh SP*, Wahajuddin*§ and Jain GK (2011) Intravenous Pharmacokinetics and Oral Bioavailability of Biochanin A in Rats. Medicinal Chemistry Research, 20(9-S1): 16271631.(*Authors contributed equally; §Corresponding author) (Impact Factor-1.1)

69. Wahajuddin§,SheelendraPratap Singh, Kushal Patel, Tejaswini Pradhan, Hefazat Husain Siddiqui, Shio Kumar Singh (2011) Prediction of human absorption of trioxane antimalarial (99-411) using in-house validated in-situ single-pass intestinal perfusion model. Arzneimittel-Forschung/Drug Research. 61(10): 1-6 PMID: 22029231(§Corresponding author) (Impact Factor-1)

70. Wahajuddin (2011) Young Investigator: Wahajuddin. Bioanalysis. 3(8): 839-841. PMID: 21510757 (Impact Factor-3.34)

71. Singh SP*, Wahajuddin*§,Tewari D, Pradhan T and Jain GK (2011) PAMPA permeability, plasma protein binding, blood Partition, pharmacokinetics and metabolism of formononetin, a methoxylatedisoflavone. Food and Chemical Toxicology. 49(5):1056-62. PMID: 21266188, (*Authors contributed equally; §Corresponding author) (Impact Factor-2.60)

72. Wahajuddin§, Singh SP, Singh SK and Jain GK (2011) Quantitation of Lumefantrine in biological matrices. Curr. Pharm. Anal. 7(1): 42-46.(§Corresponding author)(Impact Factor-1.71)

Co-author 73. Sarika Singh, Poonam Goswami, SupriyaSwarnkar, Sheelendra P Singh,

Wahajuddin, ChandishwarNath, Sharad Sharma (2011) A Study to evaluate the effect of nootropic drug - piracetam on DNA damage in leukocytes and macrophages. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 726(1):66-74. PMID: 21920458 (Impact Factor-2.938)

74. Suryawanshi S, Wahajuddin, Gupta RC and Singh SK (2011) Preclinical Pharmacokinetics, Dose Proportionality, Gender Difference and Protein Binding Study of 16-Dehydropregnenolone, an Antihyperlipidemic Agent, in Rats. Journal of Pharm. and Pharmacol. 63(1):41-8. PMID-21155814(Impact Factor-1.91)

2010

Corresponding author 75. Wahajuddin§,SheelendraPratap Singh* and Girish Kumar Jain (2010)

“Pharmacokinetics and Bioavailability of Lumefantrine, a Highly Protein Bound

21

Antimalarial in Rats” AAPS Journal. 12(S2): W4374. (§Corresponding author) (Impact Factor-3.8)

76. SheelendraPratap Singh*, Wahajuddin*§and Girish Kumar Jain (2010) “Simultaneous determination of four isoflavones in rat plasma by LC-ESI-MS/MS: Assay development, validation and application to pharmacokinetic study” AAPS Journal. 12(S2): T2313. (*Authors contributed equally; §Corresponding author) (Impact Factor-3.8)

77. Singh SP*, Wahajuddin*§, Ali MM, Jain GK (2010) Determination and pharmacokinetic study of biochanin A and its metabolite genistein in rat plasma by liquid chromatography–mass spectrometry. Journal of Separation Science, 33 (21): 3326-34. PMID: 21049521. (Impact Factor-2.63)(*Authors contributed equally; §Corresponding author)

78. Singh SP*, Wahajuddin*§, Jain GK.,(2010)Determination of curcumin in rat plasma by liquid–liquid extraction using LC–MS/MS with electrospray ionization: Assay development, validation and application to a pharmacokinetic study. Journal of Bioanalysis & Biomedicine. 2(4): 79-84.(*Authors contributed equally; §Corresponding author)

Co-author 79. Singh SP*, Wahajuddin*, Yadav DK, Rawat P, Maurya R, Jain GK (2010)

Quantitative determination of formononetin and its metabolite in rat plasma after intravenous bolus administration by HPLC coupled with tandem mass spectrometry. Journal of Chromatography B. 878 (3-4): 391-7. PMID: 20034859 (Impact Factor-2.78) (*Authors contributed equally)

80. Abnish K. Gautam, BijuBhargavan, Abdul M. Tyagi, Kamini Srivastava, Dinesh K. Yadav, Manmeet Kumar, Akanksha, Jay S. Mishra, Amar Bahadur Singh, SabyasachiSanyal, Rakesh Maurya, Lakshmi Manickavasagam, Sheelendra P. Singh, Wahajuddin, Girish K. Jain, Naibedya Chattopadhyay, Divya Singh (2011) Effects of MathoxylatedDaidzeins, Cladrin and Formononetin on Osteoblast function, Peak Bone Mass achievement and Bioavailability. J NutrBiochem. 22(4):318-327.PMID: 20579866(Impact Factor-4.35)

81. KunalSharan, Gaurav Swarnkar, Jawed A Siddique, Avinash Kumar, PreetiRawat, Manmeet Kumar, Geet K Nagar, Lakshmi Manickavasagam, Sheelendra P Singh; Geetanjali Mishra, Wahajuddin, Girish K Jain, Rakesh Maurya, Naibedya Chattopadhyay (2010) A Novel Flavonoid, 6-C-β-D-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone, Isolated From Ulmuswallichiana-Planchon Mitigates Ovariectomy-induced Osteoporosis in Rats. Menopause. 17(3): 577-86. PMID: 20393370(Impact Factor-3.45)

82. Wahajuddin*, SheelendraPratap Singh* and Girish Kumar Jain (2010) Determination and Pharmacokinetic Study of Biochanin A and Its Metabolite Genistein in Rat Plasma by Liquid Chromatography–Mass Spectrometry. Medicinal Chemistry Research, 19:S136-S137.(*Authors contributed equally) (Impact Factor-1.1)

2009 Co-author

22

83. Wahajuddin, Singh SP and Jain GK (2009) Determination of lumefantrine in rat plasma by liquid-liquid extraction using LC-MS/MS with electrospray ionization: Assay development, validation and application to pharmacokinetic study, Journal of Chromatography B .877 (11-12): 1133-1139.PMID: 19285925(Impact Factor-2.78)

2008

Co-author 84. Singh SP, Singh RSP, Wahajuddin, Jain GK (2008) “Development, validation of a

rapid, sensitive liquid chromatography-tandem mass spectrometry method using electrospray ionization for quantitation of Centchroman in rat plasma and its application to preclinical pharmacokinetic study”, Journal of Chromatography B . 876 (1): 1-7. PMID: 19004674 (Impact Factor-2.78)

2006 Co-author

85. Wahajuddin, Shinde R, Deswal S, Aggarawal A, Kadam R, Garg D, Fransis SM, Singh P and BharatamPV“Pharmacoinformatics: Expanding Horizons I” Pharmabiz, January 10, 2006.

86. Wahajuddin, Shinde R, Deswal S, Aggarawal A, Kadam R, Garg D, Fransis SM, Singh P and BharatamPV“Pharmacoinformatics: Expanding Horizons II” Pharmabiz, January 18, 2006.

2005

Co-author 87. Wahajuddin,Shinde R, Garg D,and Mohan CG, 2005 “Impact of Structural

Bioinformatics on Drug Discovery”, Current Research and Information on Pharmaceutical Sciences (CRIPS), 6 (3): 17-23. (Impact Factor)

88. WahajuddinandBansal P., “IPR Issues in Stem Cell Banking”, Current Research and Information on Pharmaceutical Sciences (CRIPS), 7 (1): 4-7.(Impact Factor)

2002

Co-author 89. Wahajuddin andNegiSeema (2002) "Pharmacy: The Authentic Profession",

"Science Reporter",NISCAIR (CSIR), New Delhi, 39 (1): 61-63.

Book Chapters:

1. Anuj Garg, KripalBhalala, Devendra Singh Tomar and Muhammad Wahajuddin

(2017) “Nanomedicine: Emerging Trends in Treatment of Malaria” In book:

Antimicrobial Nanoarchitectonics:From Synthesis to Applications, pp.475-509

edited by AlexandruGrumezescu published by Elsevier.

23

2. IshaTaneja, Kanumuri Siva Rama Raju, Wahajuddin§(2015) “Dried Blood Spots

for Neonates and Pediatric Populations” intheebook entitled “Alternative

sampling strategies in toxicology and TDM” edited by Christophe Stove, Ghent

University, Belgium published by Future Science Group, UK. Pp: 54-65.

3. Wahajuddin§, IshaTaneja and Kanumuri Siva Rama Raju (2013) Nanoparticles in

Magnetic Resonance Imaging in Nanotechnology in Modern Medical Imaging and

Interventions (Edited by Xiaoming Yang) published by Nova Science Publishers Inc

New York. Pp:67-86.

4. Wahajuddin§andSumit Arora (2013)High-throughput Quantification of

Pharmacologically Active Isoflavones using LC-UV/PDA and LC-MS/MS in Food

and Nutritional Components in Focus No. 5 Isoflavones: Chemistry, Analysis,

Function and Effects. Edited by Victor R Preedy. Published by the Royal Society

of Chemistry.Pp:218-243.

5. Wahajuddin, SheelendraPratap Singh and G.K. Jain, “Simultaneous Quantitation

of Formononetin and Daidzein by LC-MS/MS” in “11th ISMAS Triennial

International Conference on Mass Spectrometry (11th ISMAS-TRICON-

2009)” Edited by S.K.Aggarwal, P.G.Jaison, Arnab Sarkar, Pranaw Kumar (ISBN:

978-81-904442-2-4) published by Indian Society for Mass Spectrometry

(ISMAS).

6. SheelendraPratap Singh,Wahajuddinand G.K. Jain, “Simultaneous

Determination of Biochanin A and Genistein by LC-MS/MS” in “11th

ISMAS Triennial International Conference on Mass Spectrometry (11th

ISMAS-TRICON-2009)” Edited by S.K.Aggarwal, P.G.Jaison, Arnab Sarkar,

Pranaw Kumar (ISBN: 978-81-904442-2-4) published by Indian Society for Mass

Spectrometry (ISMAS).

Lectures delivered Overseas:

1. 16thIUBMB Conference 2016 on ‘Signalling Pathways in Development, Disease and

Aging’ jointly organized by the International Union of Biochemistry and Molecular

Biology (IUBMB), the Canadian Society for Molecular Biosciences (CSMB) and the

Pan-American Association for Biochemistry and Molecular Biology (PABMB) at the

Vancouver Convention Centre in Vancouver, British Columbia, Canada.

2. Biovision 2016 by Academy of Sciences in Developing World (TWAS) and the

Foundation Pour l’Université de Lyon at Lyon (France)

24

3. American Association of Pharmaceutical Scientists 2013 at the Henry B. Gonzalez

Convention Center in San Antonio, USA.

4. Miami 2013 Winter Symposium: The Molecular Basis of Metabolism and Nutrition

organised by University of Miami, Nature Publishing Group and Scripps Florida at

JW Marriot Marquis Miami, FL, USA.

5. FIP Pharmaceutical Sciences World Congress 2010 in association with the AAPS

Annual Meeting and Exposition (PSWC2010) organized by International

Pharmaceutical Federation and American Association of Pharmaceutical Scientists at

the Ernest N. Morial Convention Center in New Orleans Louisiana, USA.

Invited Lecture:

1. Issues and Options in Bioavailability of Antimalarials : Road Travelled and Way

forward delivered in National Conference on “Nanosciences, Nanotoxicology, and

Nanoinformatics-present and Future Perspectives” during 14th – 15th March 2015

at Integral University, Lucknow

2. Exploring Bio-analytical Chemistry Approaches for Analytical Toxicology

Applications delivered on“34th Inaugural Session of Academy of Environmental

Biology and National Seminar on Challenges for Sustainability of Natural

Resources and Environment” during 10th-12th October 2014 at G.B. Pant

University of Agriculture and Technology, Pantnagar.

3. Responsible use of Medicines: Role of Pharmacist on 21st November 2014delivered

in“National Pharmacy Week 2014”organized by Sam Higginbottom Institute of

Agriculture, Technology and Science, Allahabad.

4. Recent Trends in Drug Discovery and Developmentdelivered in National

Conference on “Leads for Futuristic Biotechnological Inputs: Indian Context”

during March 26-27, 2010 organized by Institute of Applied medicine and

Research, Ghaziabad.

5. Quantitation of active pharmaceutical substance in biological samples by LC-

MS/MS on 02-12-2008 in Sophisticated Analytical Instrument facility (SAIF)

Users Meet at CDRI, Lucknow

6. Series of lectures on Intellectual Property (IP) & Technology Management (TM),

Pharmacological basis of parasitic diseases and Biopharmaceutics &

Pharmacokinetics at NIPER Raebareli.

25

Institutional committee memberships-

• Member, NIPER Raebareli management committee

• Committee Member for the selection of “Best Oral Presentation Diamond Jubilee

Award” under the Pharmaceutical Sciences Group, CDRI.

• Member, organizing committee “1st Symposium on Medicinal Chemistry and

Pharmaceutical Sciences” during March 24th -26th 2009 organized by CDRI and

NIPER-Raebareli.

• Member, organizing committee “1st convocation of NIPER Raebareli” on Dec. 15th

2010 organized by CDRI and NIPER-Raebareli.

• Member, organizing committee “3rd Symposium on Medicinal Chemistry and

Pharmaceutical Sciences” during March 3rd - 5th 2011 organized by CDRI and

NIPER-Raebareli

• Member, organizing committee “4th Symposium on Medicinal Chemistry and

Pharmaceutical Sciences” during March 3rd - 5th 2012 organized by CDRI and

NIPER-Raebareli

Abstracts Published/Poster/Oral Presentations:

7th Young Investigators Meeting 2015 during March 27th-31st , 2015 organized by

IndiaBioScienceat The Khyber Himalayan Spa and Resort in Gulmarg, Jammu and

Kashmir, INDIA.

Applied Pharmaceutical Analysis –INDIA, during February 22nd -25th 2015

organized by The Boston Society at Ramada Powai Hotel and Convention Center in

Mumbai, INDIA

AAPS Annual Meeting and Exposition during November 10th-14th, 2013 organized

by American Association of Pharmaceutical Scientists at the Henry B. Gonzalez

Convention Center in San Antonio, USA.

AAPS Annual Meeting and Exposition during November 10th-14th, 2013 organized

by American Association of Pharmaceutical Scientists at the Henry B. Gonzalez

Convention Center in San Antonio, USA.

26

Miami 2013 Winter Symposium: The Molecular Basis of Metabolism and Nutrition

during February 10th-13th, 2013 organised by University of Miami, International

Union of Biochemistry and Molecular Biology, Nature Publishing Group and

Scripps Florida at JW Marriot Marquis Miami, FL, USA.

5th NIPER (RBL)-CDRI Symposium on ‘Medicinal Chemistry and Pharmaceutical

Sciences’ during March 21st-23rd, 2013 at Central Drug Research Institute,

Lucknow organized by CDRI, Lucknow and NIPER, Raebareli.

4th NIPER (RBL)-CDRI Symposium on ‘Medicinal Chemistry and Pharmaceutical

Sciences’ during February 23th-25th, 2012 at Central Drug Research Institute,

Lucknow organized by CDRI, Lucknow and NIPER, Raebareli.

(Best Poster Award)

4th NIPER (RBL)-CDRI Symposium on ‘Medicinal Chemistry and Pharmaceutical

Sciences’ during February 23th-25th, 2012 at Central Drug Research Institute,

Lucknow organized by CDRI, Lucknow and NIPER, Raebareli.

National Institute of Pharmaceutical Education and Research (NIPER), S. A. S.

Nagar by Bristol-Myers Squibb.

17th -19th Feb. 2012 organized at National Institute of Pharmaceutical Education

and Research (NIPER), S. A. S. Nagar by Bristol-Myers Squibb.

17th -19th Feb. 2012 organized at National Institute of Pharmaceutical Education

and Research (NIPER), S. A. S. Nagar by Bristol-Myers Squibb.

17th -19th Feb. 2012 organized at National Institute of Pharmaceutical Education

and Research (NIPER), S. A. S. Nagar by Bristol-Myers Squibb.

International Symposium on Recent Advances in “Green Chemistry” and

“Chromatographic Sciences” during Jan. 12th – 14th, 2012 organized by Indian

Society of Analytical Scientists, Delhi Chapter(Best Poster Award)

48th Annual Convention of Chemists 2011 and the Celebration of the

International Year of Chemistry during Dec. 2nd to 7th 2011 organized by Indian

Chemical Society at Allahabad University, Allahabad.

48th Annual Convention of Chemists 2011 and the Celebration of the

International Year of Chemistry during Dec. 2nd to 7th 2011 organized by Indian

Chemical Society at Allahabad University, Allahabad.

27

5th Annual Convention ofAssociation of Biotechnology and Pharmacy during Dec.

7th – 9th, 2011 organized by Department of Biotechnology, Karunya University,

Coimbatore

FIP Pharmaceutical Sciences World Congress 2010 in association with the AAPS

Annual Meeting and Exposition (PSWC2010) during November 14 - 18, 2010

organized by International Pharmaceutical Federation and American Association of

Pharmaceutical Scientists at the Ernest N. Morial Convention Center in New Orleans

Louisiana, USA.

FIP Pharmaceutical Sciences World Congress 2010 in association with the AAPS

Annual Meeting and Exposition (PSWC2010) during November 14 - 18, 2010

organized byI International Pharmaceutical Federation and American Association of

Pharmaceutical Scientists at the Ernest N. Morial Convention Center in New Orleans

Louisiana, USA.

National Conference on “Leads for Futuristic Biotechnological Inputs: Indian

Context” during March 26-27, 2010 organized by Institute of Applied Medicine

and Research, Ghaziabad

2nd NIPER (RBL)-CDRI Symposium on ‘Medicinal Chemistry and Pharmaceutical

Sciences’ during March 25-27, 2010 at Central Drug Research Institute, Lucknow

organized by CDRI, Lucknow and NIPER, Raebareli.

2nd International Symposium on Drug Metabolism and Pharmacokinetics

(DMPK): Applications toward Drug Discovery and Development” during 27th -

28th Feb. 2010organized at National Institute of Pharmaceutical Education and

Research (NIPER), S. A. S. Nagar by Bristol-Myers Squibb.

2nd International Symposium on Drug Metabolism and Pharmacokinetics

(DMPK): Applications toward Drug Discovery and Development” during 27th -

28th Feb. 2010 organized at National Institute of Pharmaceutical Education and

Research (NIPER), S. A. S. Nagar by Bristol-Myers Squibb.

“4th International Symposium on Current Trends in Drug Discovery Research”

during February 17th - 21st 2010 to be organized by CDRI, Lucknow.

“14thISCB International Conference (ISCBC-2010) on Chemical Biology For

Discovery; Perspectives And Challenges” during January 15 – 18, 2010 at CDRI,

Lucknow.

28

“14thISCB International Conference (ISCBC-2010) on Chemical Biology for

Discovery; Perspectives and Challenges” during January 15 – 18, 2010 at CDRI

Lucknow.

“11th ISMAS Triennial International Conference on Mass Spectrometry (11th

ISMAS-TRICON-2009)” during November 24-28, 2009 at Hyderabad, India

organizedby Indian Society for Mass Spectrometry (ISMAS).

“11th ISMAS Triennial International Conference on Mass Spectrometry (11th

ISMAS-TRICON-2009)” during November 24-28, 2009 at Hyderabad, India

organizedby Indian Society for Mass Spectrometry (ISMAS).

Advanced School in Biotechnology in India on “Biologics: Discovery to

Development” during 27 October-3 November 2009 at Gurgaon, India organized by

International Union of Biochemistry and Molecular Biology (IUBMB), UNESCO

Regional Centre of Biotechnology Training and Education (RCBTE) India and

International Centre for Genetic Engineering and Biotechnology (ICGEB) India.

“International Symposium on Pharmaceutical and Biomedical Analysis” during

1st-4thMarch 2009 organized at Agra, organized by Journal Pharmaceutical and

Biomedical Analysis.

“Drug Metabolism and Pharmacokinetics (DMPK) Symposium: Applications

toward Drug Discovery and Development” during 13th -14th Feb. 2009 organized at

National Institute of Pharmaceutical Education and Research (NIPER), S. A. S.

Nagarorganized by Bristol-Myers Squibb.

1stCDRI-NIPER (RBL) Symposium on Medicinal Chemistry and Pharmaceutical

Sciences, 24th - 26th March, 2009 held at Central Drug Research Institute (CDRI),

Lucknow.

“1st Symposium on Medicinal Chemistry and Pharmaceutical Sciences” during

March 24th -26th 2009 organized by CDRI and NIPER-Raebareli

“International Conference on Organic Chemistry and Chemical Biology” during

6-9 Jan. 2006 organized at National Chemical Laboratory, Pune by Council of

Scientific and Industrial Research (Govt. of India) and American Chemical

Society, U. S. A.

“International Conference on Organic Chemistry and Chemical Biology” during

6-9 Jan. 2006 organized at National Chemical Laboratory, Pune by Council of

29

Scientific and Industrial Research (Govt. of India) and American Chemical

Society, U. S. A.

“Workshop onPharmacoinformatics: QSAR” during 1-3 March, 2006 organized at

NationalInstitute of Pharmaceutical Education and Research (NIPER), S. A. S.

Nagar

National Conference on “BIOTECH2005” during 22-24 Dec. 2005 organized by

Centre for Biotechnology, Jawaharlal Nehru University (J.N.U.), New Delhi.

“International Conference on Drug Discovery: Perspectives and Challenges”

during 24-26 Feb. 2006 organized at Central Drug Research Institute (CDRI),

Lucknow.

Trainings undergone:

Attended workshop on “Research Methodology Workshop on

Pharmacodynamics and Pharmacokinetics”during May 1st to 8th 2012

organized by ICMR at ACTREC Mumbai.

Attended workshop on Achieving Excellence @Workplace duringJan. 30th– Feb.

1st2012 organized by CSIR- HRD Centre New Delhi.

Attended “Science & Communication Workshop” during June 7th – 9th2011 at

Hyderabad organized by The Welcome Trust/DBT India Alliance

Attended Fourth Workshop on “Data Analysis Methods using Population

Approach (Introductory and Intermediate Level)” during June 2nd – 4th 2011at

Coimbatore organized by Population Approach Group of India.

Attended International Workshop on “Safety Pharmacology” during Apr. 13th -

14th 2011 at Bangalore organized by Safety Pharmacology Society and Advinus

Therapeutics.

Attended International Workshop on “Recent Trends in IP Practice and

Management” during Oct. 5th-6th 2010 organized by CDRI (CSIR) and United

States Patent and Trademark Office, USA.

Attended Five Day National Workshop on “Application of Chromatography

and Mass Spectrometry in Clinical Research” at Bioequivalence Study Centre,

Department of Pharmaceutical Technology, Jadavpur University, Kolkata-700032

during Sept. 20th to 24st 2010 organized by Dept. of Sc. and Tech., Govt. of India.

30

Attended Training Programme on “Research Methodology” under National

Programme for Training of Scientists and Technologists working in Government

Sector” at AIIMS, New Delhi during Aug. 16th to 21st 2010 organized by Dept. of

Sc. and Tech., Govt. of India.

Attended International Short Course and Workshop on Applied

Pharmaceutical Analysis at Hyderabad during Feb. 21st-25th 2010 organized by

Boston Society, USA

Attended Advanced Workshop on Patent Strategies (Patent Analysis,

Landscaping, Drafting, Prosecution, IP Valuation & Portfolio Management )

during Feb. 1st – 4th 2010 organized by HRD Centre, CSIR and Global Institute of

Intellectual Property, New Delhi.

Attended Advanced School in Biotechnology in India on “Biologics: Discovery

to Development” during 27 October-3 November 2009 at Gurgaon, India

organized by International Union of Biochemistry and Molecular Biology

(IUBMB), UNESCO Regional Centre of Biotechnology Training and

Education (RCBTE) India and International Centre for Genetic Engineering

and Biotechnology (ICGEB) India.

Attended training workshop and symposium on Quantitative Analysis and

Modeling in Animal Sciences during Oct. 6th-11th 2009 at Pune, India organized

by Department of Science & Technology, Govt. of India in collaboration

withCentre for Cellular and Molecular Biology Hyderabad, National

Chemical Laboratory Pune and Indian Institute of Science Education and

Research, Pune.

Attended LC-MS/MS User Meet of Applied Biosystems and Lab India during

Nov. 28th to Dec. 1st 2008 at Jaipur.

Attended Induction Training Programmefor CSIR Scientists at

Ghaziabadorganized by Human Resource Development Centre (CSIR),

Ghaziabad.

Attended International Biomedical Modeling School and Workshop 2008 with

full financial support from University of Graz, Austria and CAM, TIFR

during Feb. 27th to March 2nd, 2008 at Bangaloreorganized by University of Graz

and Centre for Applicable Mathematics, TIFR

31

Attended WHO/TDR training workshop with full financial support from WHO

on Good Laboratory Practice during 29th – 31st October, 2007 at Bangalore,

organized by WHO-TDR GLP Network, Regional Coordination (Asia),

Industrial Toxicology Research Centre, Lucknow

Participated in “Quality of Measurements” training during March 11th -12th 2007

at CDRI, Lucknow.

Completed short course on “Computational Neuroscience (CNS2005)” at

School of Biosciences and Bioengineering, Indian Institute of Technology

Bombay, Pawai (Mumbai) in collaboration with National Brain Research

Centre (Dept. of Biotech., Govt. of India), Manesar (Gurgaon).

32

Travelships/Fellowships/Competitionswon:

• Author Scientific Credit Award for most downloaded article in the Journal of Bioanalysis & Biomedicine by OMICS Publishing Group, USA.

• Travel grant (for local hospitality) under CSIR Travel Grant Scheme for

Conference Participation Abroad (For CSIR Regular Scientists)from

International Science & Technology Affairs Directorate (ISTAD), Council

of Scientific & Industrial Research (CSIR) for FIP Pharmaceutical

Sciences World Congress 2010 in association with the AAPS Annual

Meeting and Exposition (PSWC2010) during November 14 - 18, 2010

organized by International Pharmaceutical Federation and American

Association of Pharmaceutical Scientists at the Ernest N. Morial Convention

Center in New Orleans Louisiana, USA.

• Travelshipfrom Dept. of Sc. & Tech. under international travel support

scheme for FIP Pharmaceutical Sciences World Congress 2010 in

association with the AAPS Annual Meeting and Exposition (PSWC2010)

during November 14 - 18, 2010 organized by International Pharmaceutical

Federation and American Association of Pharmaceutical Scientists at the

Ernest N. Morial Convention Center in New Orleans Louisiana, USA.

• Travelship and local hospitality from DST for training workshop on

Quantitative Analysis and Modeling in Animal Sciences during Oct. 6th-11th

2009 at Pune

• Travelship and local hospitality from ICGEB and IUBMB for Advanced

School in Biotechnology in India on “Biologics: Discovery to Development”

• Travelship and local hospitality fromUniversity of Graz, Austria and

CAM, TIFR for International Biomedical Modeling School and Workshop.

• Travelship and local hospitality fromWHO/TDR for training workshop

onGood Laboratory Practice.

• Travelship and local hospitality from DBT for short course on

“Computational Neuroscience (CNS2005)”

• Qualified Graduate Aptitude Test in Engineering 2004 organized by IIT Delhi.

33

• Awardee of “Scholarship for Technical/Professional Courses 2002-03-

2004” awarded by Central Wakf council, Govt. of India

• Won First prize in “Debate Competition” organized by Dept. of Pharm. Sc.,

HNB Garhwal University, Srinagar (Uttaranchal)

• Won First prize in “Poetry Competition” organized by NIPER, Mohali.

• Won “PratibhashaliplusVidyarthiParitoshikSpardha 2002” organized at

Lucknow by SahiPratibhaProtsahan Munch, unit of Corona Plus Industries

Ltd., Mumbai.

• Won First prize in a no. of Debate, Essay and extempore competitions.

Membership of Professional Organizations:

Elected Life member of National Academy of Sciences (India)

Elected Life member of National Academy of Medical Sciences (India)

Life member of Indian Society for Mass Spectrometry

Life member of Indian Pharmacological Society

Life member of Indian Science Congress Association

Life member of IDMA- Association of Pharmaceutical Analysts (APA)

Life member of Laboratory Animal Science Association of India

Life member of Biotechnology Research Society of India

Life member of Indian Society of Analytical Scientists

Life member of Association of Biotechnology and Pharmacy

Life member of Society of Biological Chemists, India

Life member of Society of Applied Biotechnology, India

Personal Details:

Date of birth : 11th February 1981

Father's Name : Mr. Fariuddin

34

Hobbies : Flair for Technical (Scientific) Writing,

Traveling,Watching Movies& Music.

Strengths : A clear vision & a commitment to my aim; Hard

working, Energetic, Mentally strong for long working

schedules; Excellent communication skills.

Permanent Address : DrWahajuddin S/o Mr. Fariuddin, C/o Farman Clinic,

Villege-Bhanera, Via-Kiratpur, Bijnore-246731, UP,

India.

Phone No. : +91-0522-2772450, 2772550

Extn.-4849 (Office) 4850 (Lab)

E-mail : wahajuddin@gmail.com, wahajuddin@cdri.res.in